PRODUCTS
Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
---|---|---|---|---|---|---|---|
Doxycycline Hyclate Tablets | 75mg |
|
60 |
68180-653-07 |
Acticlate |
AB |
Tetracycline Antibiotics |
Doxycycline Monohydrate Capsules USP | 50mg |
|
50 |
68180-650-01 |
Monodox® |
AB |
Anti-Infectives |
Drospirenone & Ethinyl Estradiol Tablets USP | 3mg/0.03mg |
|
28 x 3 |
68180-0902-73 |
Yasmin® |
AB |
Oral Contraceptives |
Drospirenone, Ethinyl Estradiol & Levomefolate Calcium & Levomefolate Calcium Tablets | 3mg/0.02mg/0.451mg and 0.451mg |
|
3 x 28 |
68180-0894-73 |
Beyaz® |
AB |
Oral Contraceptives |
Duloxetine Hydrochloride DR Capsules USP | 20mg |
|
30 |
68180-0295-03 |
Cymbalta® |
AB |
Antidepressant |
Enskyceâ„¢ | 0.15 mg /0.03 mg |
|
28 x 3 |
68180-891-73 |
Ortho-Cept® |
AB |
Oral Contraceptives |
Ethacrynic Acid Tablets | 25mg |
|
100 |
68180-0159-01 |
Edecrin® |
AB |
Diuretic |
Ethambutol Tablets | 100mg |
|
100 |
68180-280-01 |
Myambutol® |
AB |
Antimycobacterial agent |
Fenofibrate Capsules | 90mg |
|
30 |
68180-746-06 |
Antara® |
AB |
Antihyperlipidemic |
Fenofibrate Capsules | 43mg |
|
30 |
68180-0130-06 |
Antara® |
AB |
Antihyperlipidemic |
Fenofibrate Tablets | 48mg |
|
90 |
68180-360-09 |
Tricor® |
AB |
Antihyperlipidemic agent |
Fenofibrate Tablets | 54mg |
|
90 |
68180-231-09 |
Lofibra® |
AB |
Antihyperlipidemic agent |
Flucytosine Capsules USP | 250 mg |
|
100 |
43386-771-01 |
Ancobon® |
AB |
Antifungal |
Fluocinonide Topical Solution USP | 0.05% |
|
20 mL |
43386-026-02 |
Lidex® |
AT |
Corticosteroid |
Fluoxetine Tablets USP | 10mg |
|
30 |
68180-998-01 |
Prozac® |
AB |
Anti-depressant |
Fluoxetine Tablets USP | 60mg |
|
30 |
68180-997-06 |
Fluoxetine Tablets |
AB |
Anti-depressant |
Formoterol Fumarate Inhalation Solution | 20mcg/2mL |
|
30 UD Vials |
70748-261-30 |
Perforomist® |
AN |
Long-acting beta agonists (LABAs)/ Bronchodilator |
Fosaprepitant Dimeglumine for Injection | 150mg |
|
5mL single-dose vial |
68180-690-01 |
Emend® |
AP |
Antiemetic |
Fyavolv™ | 0.5mg/0.0025mg |
|
28 x 3 |
68180-827-09 |
FemHRT® |
AB |
Hormone Replacement Therapy |
Ganirelix Acetate Injection | 250mcg/0.5mL |
|
(1) 250mcg single-dose pre-filled syringe |
70748-274-01 |
Ganirelix Acetate Injection |
AP |
Competitive gonadotropin-releasing hormone antagonist (GnRH antagonist) |
GaviLAX (PEG3350) Powder for Oral Solution | 17gm/scoopful |
|
238g |
43386-312-14 |
MiraLAX® |
AA |
Laxative |
GaviLyteâ„¢ – C | 240 -5.84-2.98-6.72-22.72gm |
|
4 L |
43386-060-19 |
Colyte® |
AA |
Hyperosmotic |
GaviLyteâ„¢ – G | 236-5.86-2.97-6.74-22.74 gm |
|
4 L |
43386-090-19 |
GoLYTELY® |
AA |
Hyperosmotic |
GaviLyteâ„¢-N | 420-111.20-1.48-5.72 gm |
|
4 L |
43386-050-19 |
NuLYTELY® |
AA |
Hyperosmotic |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.